Laboratorio de Neurociencias, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Laboratorio de Nucleótidos, Centro de Regulación Celular y Patología, J.V. Luco, Instituto MIFAB, Departamento de Fisiología, Facultad de Ciencias Biológicas, P. Universidad Católica de Chile, Santiago, Chile.
Eur J Neurosci. 2011 Apr;33(7):1175-1185. doi: 10.1111/j.1460-9568.2010.07589.x. Epub 2011 Feb 17.
Zn²(+) is an essential ion that is stored in and co-released from glutamatergic synapses and it modulates neurotransmitter receptors involved in long-term potentiation (LTP). However, the mechanism(s) underlying Zn²(+) -induced modulation of LTP remain(s) unclear. As the purinergic P2X receptors are relevant targets for Zn²(+) action, we have studied their role in LTP modulation by Zn²(+) in the CA1 region of rat hippocampal slices. Induction of LTP in the presence of Zn²(+) revealed a biphasic effect - 5-50 μm enhanced LTP induction, whereas 100-300 μm Zn²(+) inhibited LTP. The involvement of a purinergic mechanism is supported by the fact that application of the P2X receptor antagonists 2',3'-O-(2,4,6-trinitrophenyl) ATP (TNP-ATP) and periodate-oxidized ATP fully abolished the facilitatory effect of Zn²(+) . Notably, application of the P2X₇ receptor-specific antagonist Brilliant Blue G did not modify the Zn²(+) -dependent facilitation of LTP. Exogenous ATP also produced a biphasic effect - 0.1-1 μm ATP facilitated LTP, whereas 5-10 μm inhibited LTP. The facilitatory effect of ATP was abolished by the application of TNP-ATP and was modified in the presence of 5 μm Zn²(+) , suggesting that P2X receptors are involved in LTP induction and that Zn²(+) leads to an increase in the affinity of P2X receptors for ATP. The latter confirms our previous results from heterologous expression systems. Collectively, our results indicate that Zn²(+) at low concentrations enhances LTP by modulating P2X receptors. Although it is not yet clear which purinergic receptor subtype(s) is responsible for these effects on LTP, the data presented here suggest that P2X₄ but not P2X₇ is involved.
Zn²⁺ 是一种必需的离子,它储存在谷氨酸能突触中并共同释放,调节参与长时程增强(LTP)的神经递质受体。然而,Zn²⁺ 诱导的 LTP 调制的机制仍不清楚。由于嘌呤能 P2X 受体是 Zn²⁺ 作用的相关靶点,我们研究了它们在 Zn²⁺ 调制 CA1 区大鼠海马切片中 LTP 的作用。在 Zn²⁺ 存在下诱导 LTP 显示出双相作用 - 5-50 µm 增强 LTP 诱导,而 100-300 µm Zn²⁺ 抑制 LTP。P2X 受体拮抗剂 2',3'-O-(2,4,6-三硝基苯)ATP(TNP-ATP)和过碘酸盐氧化 ATP 的应用事实支持了嘌呤能机制的参与,完全消除了 Zn²⁺ 的促进作用。值得注意的是,P2X₇ 受体特异性拮抗剂 Brilliant Blue G 的应用并未改变 Zn²⁺ 依赖性 LTP 增强。外源性 ATP 也产生了双相作用 - 0.1-1 µm ATP 促进 LTP,而 5-10 µm 抑制 LTP。TNP-ATP 的应用消除了 ATP 的促进作用,并在 5 µm Zn²⁺ 存在下改变了 LTP,表明 P2X 受体参与 LTP 诱导,Zn²⁺ 导致 P2X 受体对 ATP 的亲和力增加。后者证实了我们从异源表达系统获得的先前结果。总的来说,我们的结果表明,低浓度的 Zn²⁺ 通过调节 P2X 受体增强 LTP。虽然目前尚不清楚哪种嘌呤能受体亚型负责这些对 LTP 的影响,但这里提供的数据表明 P2X₄ 但不是 P2X₇ 参与其中。